The investigators anticipate a reduced risk of post-operational de novo stress urinary incontinence following surgery for prosthetic vaginal sacrospinofixation, associated with reduced costs, comparable functional and anatomical efficacy and no increase in morbidity and rate of dyspareunia with the new treatment